Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
7
×
life sciences
national blog main
boston
boston blog main
boston top stories
bristol-myers squibb
cancer
cancer immunotherapy
clinical trials
depression
drug development
gene editing
national
national top stories
novartis
samit hirawat
allergan
biologic drugs
biomarkers
boston xcon
boulder/denver xcon
brexanalone
clinical data
clinical study
crispr
cynthia collins
data
detroit xcon
digital health
disease
drugs
editas medicine
enzyme
gag
genome editing
genome sequencing
health
healthtech
hunter syndrome
What
trial
7
×
clinical
medical
medicine
acquisition
anniversary
approaches
bn
bristol
celgene
chief
company’s
corporation
depression
diversity
drug
editing
gene
hirawat
humans
myers
myers’s
officer
phase
pipeline
progress
scrip
spoke
squibb
therapeutics
year
allergan
alto
announced
approval
benefit
biologic
blessing
bosley
bottleneck
Language
unset
Current search:
trial
×
biotech
×
@techcrunch.com
2 years ago
How Cerebral and Alto Neuroscience embarked on an at-home clinical trial for depression
@xconomy.com
3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com
3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com
5 years ago
In Landmark Gene-Editing Study, Sangamo Reports Little Benefit
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
@xconomy.com
5 years ago
Sage Hits Mark in Postpartum Depression Phase 3 Trial, Stock Surges
@xconomy.com
5 years ago
Fixing the Clinical Trial Bottleneck by Making Patients a Priority
